GGrantIndex
← Search

Cancer Center Administration

$33,262P30FY2025CANIH

Research Inst Of Fox Chase Can Ctr, Philadelphia PA

Investigators

Linked publications, trials & patents

Paper 39604567Paper 39602533Paper 39554190Paper 39546469Paper 39521739Paper 39514554Paper 39371220Paper 39345610Paper 39343653Paper 39223207Paper 39207123Paper 39189642Paper 39148468Paper 39137728Paper 39072643Paper 39060143Paper 39013784Paper 39003201Paper 38982062Paper 38976159Paper 38963567Paper 38914477Paper 38871720Paper 38865671Paper 38853421Paper 38835516Paper 38815457Paper 38811332Paper 38798370Paper 38766032Paper 38747616Paper 38678525Paper 38659828Paper 38639476Paper 38638131Paper 38600381Paper 38586274Paper 38586042Paper 38559274Paper 38547779Paper 38539515Paper 38464238Paper 38452871Paper 38432028Paper 38421650Paper 38377387Trial NCT04290585Trial NCT03177057Trial NCT02594826Trial NCT02132884Trial NCT02132858Trial NCT02132845Trial NCT02110953Trial NCT02092714Trial NCT02050009Trial NCT01982591Trial NCT01962948Trial NCT01934179Trial NCT01840150Trial NCT01462630Trial NCT01316757Trial NCT01212822Trial NCT00750009Trial NCT00509626Trial NCT00458588Trial NCT00436397Trial NCT00433524Trial NCT00084591Trial NCT00084539Trial NCT00084526Trial NCT00084513Trial NCT00066677Trial NCT00062322Trial NCT00062309Trial NCT00043108Trial NCT00039520Trial NCT00039507Trial NCT00022308Trial NCT00021398Trial NCT00021372Trial NCT00021346Trial NCT00021333Trial NCT00021320Trial NCT00005037Trial NCT00003264Trial NCT00003263Trial NCT00003109Patent 9533040Patent 9182383Patent 9101603Patent 8980258Patent 8685658Patent 8609437Patent 8580263Patent 8329873Patent 7332585Patent 7332580Patent 7129057Patent 6946275Patent 6617427

Abstract

PROJECT SUMMARY/ABSTRACT – CANCER CENTER ADMINISTRATION The Cancer Center Administration (CCA) at FCCC supports Senior Leaders, FCCC Members, Shared Resources, key research departments, manages the research budget and oversees Cottman Avenue Campus (CAC) research operations and space. The Associate Director for Administration (ADA), John Gricoski, MBA, CPA is the leader of the CCA. Gricoski reports directly to Chernoff, who has ultimate responsibility and authority over the strategic direction, budget, space utilization and personnel. Chernoff has granted authority to Gricoski to oversee administrative aspects of the Cancer Center. Gricoski has been the leader of the CCA since his appointment in July 2010. Gricoski serves on several key operating committees that are critical to operations and strategic direction of the FCCC. The ADA has direct authority over four departments that form the CCA 1) Office of Sponsored Research (OSR), 2) Shared Resources Administration (SRA), 3) Grants Management Department (GMD) and 4) Administrative Research Services (ARS). The CCA ensures that all FCCC members have the requisite resources (space, personnel, and funds) to conduct cancer research efficiently and effectively. The CCA provides administrative support for the following departments, functions, and offices that are critical to achieving strategic objectives: Community Outreach and Engagement (COE), Cancer Research Training Education Coordination (CRTEC), Office of Diversity Equity Inclusion and Access (ODEIA), Research Programs, Office of Clinical Research (OCR) and SRM. The CCA serves at the central hub and organizer of Cancer Center activities across the Cottman Avenue (CAC), Health Sciences (HSC) and University Campuses (UC). Gricoski has sole responsibility for administration for FCCC members on CAC. The ADA accomplished the following during this funding period by facilitating the: 1) transition to Chernoff as new CC Director; 2) development of the FCCC Strategic Plan, resulting in a reconfiguration of the Research Programs and reforming the SRM process; 3) investment of $10.6M to upgrade/renovate 11 Shared Resources (SR) for improved research efficiency and productivity; 4) creation of three new senior leadership positions; 5) establishment of new ODEIA office and expansion of COE; 6) receipt of over 280 awards, a success rate of 28%; 7) 17 pilot grant competitions that yielded 20 new grants and $17M of additional direct costs since 2019 and 8) facilitated cancer center membership for 31 new faculty hires since 2019. These and other administrative accomplishments have contributed to improvements in key metrics of success (2019-2023), including increases in Multi-PI Grants (+90%), NCI Funding (+12%), and Peer Reviewed funding (+21%). Over the next funding period, the ADA and CCA will 1) Monitor execution of the 2022-2027 FCCC Strategic Plan, SPRINT; 2) Expand efforts to optimize integration with the UC, and HSC, in particular LKSOM; 3) Assist with submission of multi-PI NCI grants, as well as K and T training grants, and 4) Assist with faculty recruitment in areas aligned with the Strategic Plan and the Plan to Enhance Diversity.

View original record on NIH RePORTER →